<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="coa14257" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Otolaryngol</journal-id><journal-id journal-id-type="iso-abbrev">Clin Otolaryngol</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">COA</journal-id><journal-title-group><journal-title>Clinical Otolaryngology</journal-title></journal-title-group><issn pub-type="ppub">1749-4478</issn><issn pub-type="epub">1749-4486</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11792432</article-id><article-id pub-id-type="pmcid-ver">PMC11792432.1</article-id><article-id pub-id-type="pmcaid">11792432</article-id><article-id pub-id-type="pmcaiid">11792432</article-id><article-id pub-id-type="pmid">39629563</article-id><article-id pub-id-type="doi">10.1111/coa.14257</article-id><article-id pub-id-type="publisher-id">COA14257</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Epidemiology of Cholesteatoma in the <styled-content style="fixed-case" toggle="no">UK</styled-content> Biobank</article-title></title-group><contrib-group><contrib id="coa14257-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Wilson</surname><given-names initials="E">Emma</given-names></name><xref rid="coa14257-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>emma.wilson@uea.ac.uk</email></address></contrib><contrib id="coa14257-cr-0002" contrib-type="author"><name name-style="western"><surname>Jennings</surname><given-names initials="BA">Barbara Anne</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3792-9182</contrib-id><xref rid="coa14257-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="coa14257-cr-0003" contrib-type="author"><name name-style="western"><surname>Khondoker</surname><given-names initials="M">Mizanur</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1801-1635</contrib-id><xref rid="coa14257-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="coa14257-cr-0004" contrib-type="author"><name name-style="western"><surname>Philpott</surname><given-names initials="CM">Carl M.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1125-3236</contrib-id><xref rid="coa14257-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="coa14257-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="coa14257-cr-0005" contrib-type="author"><name name-style="western"><surname>Prinsley</surname><given-names initials="P">Peter</given-names></name><xref rid="coa14257-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="coa14257-cr-0006" contrib-type="author"><name name-style="western"><surname>Brewer</surname><given-names initials="DS">Daniel S.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4753-9794</contrib-id><xref rid="coa14257-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="coa14257-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="coa14257-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Norwich Medical School</named-content>
<institution>University of East Anglia</institution>
<city>Norwich</city>
<country country="GB">UK</country>
</aff><aff id="coa14257-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">ENT Department</named-content>
<institution>James Paget University Hospitals NHS Foundation Trust</institution>
<city>Great Yarmouth</city>
<named-content content-type="country-part">Norfolk</named-content>
<country country="GB">UK</country>
</aff><aff id="coa14257-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>Norwich and Norfolk University Hospital</institution>
<city>Norfolk</city>
<country country="GB">UK</country>
</aff><aff id="coa14257-aff-0004">
<label>
<sup>4</sup>
</label>
<institution>Earlham Institute, Norwich Research Park</institution>
<city>Norwich</city>
<country country="GB">UK</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence:</bold><break/>
Emma Wilson (<email>emma.wilson@uea.ac.uk</email>)<break/></corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2025</year></pub-date><volume>50</volume><issue seq="180">2</issue><issue-id pub-id-type="pmc-issue-id">481174</issue-id><issue-id pub-id-type="doi">10.1111/coa.v50.2</issue-id><fpage>316</fpage><lpage>329</lpage><history><date date-type="rev-recd"><day>14</day><month>10</month><year>2024</year></date><date date-type="received"><day>20</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>30</day><month>10</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>04</day><month>02</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>05</day><month>02</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-02-11 19:25:14.270"><day>11</day><month>02</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2024 The Author(s). <italic toggle="yes">Clinical Otolaryngology</italic> published by John Wiley &amp; Sons Ltd.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="COA-50-316.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:COA-50-316.pdf"/><abstract><title>ABSTRACT</title><sec id="coa14257-sec-0001"><title>Objectives</title><p>To identify factors associated with cholesteatoma in a large UK cohort. Although some risk factors are frequently reported (male sex, history of chronic otitis media), other associations require further evidence (deprivation, smoking).</p></sec><sec id="coa14257-sec-0002"><title>Design and Setting</title><p>Briefly, 1140 cholesteatoma cases from UK BioBank were compared to 4551 non&#8208;cholesteatoma middle ear disease and 493&#8201;832 ear disease&#8208;free controls. Adjusted odds ratios were calculated for demographic factors including age, sex, ethnicity, deprivation and smoking status with logistic regressions. Odds ratios for overlapping ICD&#8208;10 codes are also calculated.</p></sec><sec id="coa14257-sec-0003"><title>Results</title><p>Cholesteatoma was significantly associated with sex (Adjusted odds ratio (AOR) for males&#8201;=&#8201;1.33, 95%CI&#8201;=&#8201;[1.179&#8211;1.491]), age (AOR&#8201;=&#8201;1.02, 95%CI&#8201;=&#8201;[1.011&#8211;1.026]) and deprivation (AOR&#8201;=&#8201;1.08, 95%CI&#8201;=&#8201;[1.059&#8211;1.097]) compared to ear disease&#8208;free controls (<italic toggle="no">p</italic>&#8201;&lt;&#8201;0.001). Age and deprivation distributions for cholesteatoma and non&#8208;cholesteatoma ear disease were similar. Although there was no significant association with smoking status, cholesteatoma was significantly associated with the ICD&#8208;10 code mental and behavioural disorders due to tobacco use (OR&#8201;=&#8201;2.34, <italic toggle="no">p</italic>&#8201;&lt;&#8201;0.001, 95%CI&#8201;=&#8201;[1.942, 2.813]). Cholesteatoma was also strongly associated with a wide range of inflammatory middle ear conditions and chronic sinus inflammation, suggesting an increased susceptibility to inflammation of the upper airways.</p></sec><sec id="coa14257-sec-0004"><title>Conclusion</title><p>This study shows a large overlap between cholesteatoma and non&#8208;cholesteatoma ear disease in terms of numbers and demographics, with sex being a key factor distinguishing between the two, suggesting that there are both common and distinct associated factors.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="coa14257-kwd-0001">cholesteatoma</kwd><kwd id="coa14257-kwd-0002">epidemiology</kwd><kwd id="coa14257-kwd-0003">hearing loss</kwd><kwd id="coa14257-kwd-0004">middle ear</kwd><kwd id="coa14257-kwd-0005">otitis media</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>Bernice Bibby Research Trust</funding-source></award-group><award-group id="funding-0002"><funding-source>University of East Anglia Faculty of Medicine and Health Sciences</funding-source></award-group></funding-group><counts><fig-count count="3"/><table-count count="3"/><page-count count="14"/><word-count count="6700"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.3 mode:remove_FC converted:04.02.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="coa14257-ntgp-0001"><fn fn-type="funding" id="coa14257-note-0001"><p>
<bold>Funding:</bold> Funding for the studentship associated with this project was provided by the University of East Anglia Faculty of Medicine and Health Sciences. Funding for the greater Genetics of Cholesteatoma project was provided by the Bernice Bibby Research trust.</p></fn></fn-group></notes></front><body id="coa14257-body-0001"><p>
<boxed-text position="anchor" content-type="box" id="coa14257-blkfxd-0001" orientation="portrait"><caption><title>Summary</title></caption><p>
<list list-type="bullet" id="coa14257-list-0001"><list-item id="coa14257-li-0001"><p>We present the first epidemiological study of cholesteatoma using data from UK BioBank.</p></list-item><list-item id="coa14257-li-0002"><p>We identified 1140 cholesteatoma cases from the UK Biobank cohort. These cases were compared with two different control groups: matched ear disease controls and ear disease&#8208;free controls.</p></list-item><list-item id="coa14257-li-0003"><p>Demographic and ICD&#8208;10 data are comprehensively summarised from our case&#8211;control study.</p></list-item><list-item id="coa14257-li-0004"><p>Cholesteatoma was significantly associated with male sex, increasing age and greater deprivation.</p></list-item><list-item id="coa14257-li-0005"><p>Associations were shared between cholesteatoma and other inflammatory middle ear diseases, but male sex was a risk factor distinguishing these groups.</p></list-item></list>
</p></boxed-text>
</p><sec id="coa14257-sec-0008"><label>1</label><title>Introduction</title><sec sec-type="background" id="coa14257-sec-0009"><label>1.1</label><title>Background</title><p>Cholesteatoma is an invasive, non&#8208;cancerous cyst of the middle ear whose expansion and destruction of surrounding bone results in progressive hearing loss, discharge and potentially serious intracranial complications including meningitis and abscess [<xref rid="coa14257-bib-0001" ref-type="bibr">1</xref>]. The only known treatment is surgical excision, which itself can contribute to hearing loss. Cholesteatoma incidence varies between populations but is reported up to 9.81 per 100&#8201;000 adults per year in Finland [<xref rid="coa14257-bib-0002" ref-type="bibr">2</xref>]. Not much is known about why cholesteatoma forms but several risk factors have been identified, including male sex [<xref rid="coa14257-bib-0001" ref-type="bibr">1</xref>], family history [<xref rid="coa14257-bib-0003" ref-type="bibr">3</xref>, <xref rid="coa14257-bib-0004" ref-type="bibr">4</xref>] and certain developmental disorders affecting cranial morphology, including Turner syndrome and cleft palate [<xref rid="coa14257-bib-0005" ref-type="bibr">5</xref>]. While these risk factors are well known, associations with deprivation [<xref rid="coa14257-bib-0002" ref-type="bibr">2</xref>, <xref rid="coa14257-bib-0006" ref-type="bibr">6</xref>, <xref rid="coa14257-bib-0007" ref-type="bibr">7</xref>] and smoking [<xref rid="coa14257-bib-0008" ref-type="bibr">8</xref>] have occasionally been reported but require further investigation. Meanwhile, increased incidence in white over non&#8208;white populations is often referenced [<xref rid="coa14257-bib-0001" ref-type="bibr">1</xref>, <xref rid="coa14257-bib-0009" ref-type="bibr">9</xref>, <xref rid="coa14257-bib-0010" ref-type="bibr">10</xref>, <xref rid="coa14257-bib-0011" ref-type="bibr">11</xref>], but original epidemiological data supporting this is scant. Furthermore, cholesteatoma incidence has been shown to differ between populations and over time.</p><p>The UK BioBank (UKBB) is a database and large research resource that includes in depth health and genetic data from a cohort of ~500&#8201;000 participants recruited from the UK between 2006 and 2010. Hospital inpatient data is available for the whole cohort, with primary care data available for less than half of the participants [<xref rid="coa14257-bib-0012" ref-type="bibr">12</xref>]. Data about health and lifestyle were collected by questionnaire at recruitment and UKBB use algorithms to define health outcomes from self&#8208;reported health information, hospital inpatient data and death data.</p><p>Greater understanding of cholesteatoma, its risk factors, and relationships to other middle ear disease are needed to inform study design for the discovery of preventative measures or non&#8208;surgical treatments.</p></sec><sec id="coa14257-sec-0010"><label>1.2</label><title>Aims and Objectives</title><p>This study aims to use retrospective data about UKBB participants to characterise lifetime prevalence and demographics related to cholesteatoma amongst a cohort aged &gt;&#8201;52&#8201;years. We also compare cholesteatoma directly to non&#8208;cholesteatoma middle ear disease (NC&#8208;MED) to determine whether risk factors and associations are shared or unique. In addition, we aimed to compare these results to publicly available statistics from an equivalent Finnish Biobank, FinnGen (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.finngen.fi/en" ext-link-type="uri">https://www.finngen.fi/en</ext-link>). This will be useful for other researchers considering the use of this biobank for the study of cholesteatoma and related conditions.</p></sec></sec><sec sec-type="methods" id="coa14257-sec-0011"><label>2</label><title>Methods</title><sec id="coa14257-sec-0012"><label>2.1</label><title>Study Design and Setting</title><p>This is a retrospective case&#8211;control study of data from UKBB participants (application ID 61632) who were drawn from the UK population between 2006 and 2010 aged 40&#8211;69 at recruitment. All participants provided informed consent through electronic signature at their baseline assessment.</p><p>UKBB has obtained Research Tissue Bank (RTB) approval from its ethics committee that covers our use of downloaded data. The Research Ethics Committee (REC) approval number for UKBB is 16/NW/0274. Researchers can acquire UKBB data by registering for access: (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ukbiobank.ac.uk/enable-your-research/register" ext-link-type="uri">https://www.ukbiobank.ac.uk/enable&#8208;your&#8208;research/register</ext-link>). Publicly available demographic data and statistical results from FinnGen release 9 were accessed via Risteys (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://r9.risteys.finngen.fi/endpoints/H8_CHOLEASTOMA" ext-link-type="uri">https://r9.risteys.finngen.fi/endpoints/H8_CHOLEASTOMA</ext-link>) in June 2023.</p></sec><sec id="coa14257-sec-0013"><label>2.2</label><title>Participants</title><p>From the UKBB cohort, we identified individuals as having (or very likely having had) cholesteatoma. In this study, we use UKBB demographic data, including ethnicity, sex, birth year and deprivation and clinical classification codes from health records, to characterise cholesteatoma prevalence and associated diseases amongst this cohort.</p></sec><sec id="coa14257-sec-0014"><label>2.3</label><title>Variables</title><p>Variables examined in the Biobank and FinnGen data included:<list list-type="bullet" id="coa14257-list-0002"><list-item id="coa14257-li-0006"><p>Age, sex and ethnicity as given in response to a survey at recruitment.</p></list-item><list-item id="coa14257-li-0007"><p>Smoking status, compiled from survey results, indicating whether participants have ever smoked.</p></list-item><list-item id="coa14257-li-0008"><p>Townsend deprivation index (a measure of postcode deprivation combining employment rate, car and house ownership and household crowdedness [<xref rid="coa14257-bib-0013" ref-type="bibr">13</xref>]).</p></list-item><list-item id="coa14257-li-0009"><p>International classification of diseases (ICD&#8208;10) codes from medical records, which reflect participants' medical histories prior to recruitment and up to the date of download.</p></list-item></list>
</p><p>The UKBB participants were divided into three groups (Table&#160;<xref rid="coa14257-supitem-0001" ref-type="supplementary-material">S1</xref> contains full codes and justifications):<list list-type="bullet" id="coa14257-list-0003"><list-item id="coa14257-li-0010"><p>The cholesteatoma group, defined by ICD&#8208;10 and operative (OPC&#8208;4) codes which strongly suggest a history of cholesteatoma, including chronic mastoiditis, recurrent cholesteatoma, mastoidectomy and cholesteatoma itself.</p></list-item><list-item id="coa14257-li-0011"><p>A NC&#8208;MED group, who have any middle ear disease code or otalgia, otorrhea or otitis externa. Although not strictly a middle ear disease, otitis externa involves inflammation affecting the ear drum. Given the role of inflammation in establishment of cholesteatoma, we include this in our definition.</p></list-item><list-item id="coa14257-li-0012"><p>A control group free of middle ear disease.</p></list-item></list>
</p></sec><sec id="coa14257-sec-0015"><label>2.4</label><title>Study Size</title><p>The study size was determined by the availability of eligible data within the Biobank and FinnGen databases.</p></sec><sec id="coa14257-sec-0016"><label>2.5</label><title>Statistical Analyses</title><sec id="coa14257-sec-0017"><label>2.5.1</label><title>Logistic Regressions for Demographic Factors</title><p>Associations with demographic factors were tested by logistic regression of cholesteatoma status for cholesteatoma (<italic toggle="yes">n</italic>&#8201;=&#8201;1140) versus control (<italic toggle="yes">n</italic>&#8201;=&#8201;493&#8201;832) and cholesteatoma versus NC&#8208;MED (<italic toggle="yes">n</italic>&#8201;=&#8201;4551). Logistic regression models for the binary outcome of cholesteatoma status were fit on age, sex, smoking status, deprivation and ethnicity using the <italic toggle="yes">fitglm</italic> function with binomial error distribution and logit link function in MATLAB R2020b [<xref rid="coa14257-bib-0014" ref-type="bibr">14</xref>]. Adjusted odds ratios (AORs) were obtained for all covariates; 2884 individuals with missing smoking data were excluded from these regressions.</p><p>Sensitivity analysis was conducted to assess the robustness of the results to large case&#8211;control imbalance. We calculated unadjusted odds ratios for each variate using data matched for the remaining variates with a ratio of 1:5 cases to controls. Matching was performed using the package MatchIt (version 4.4.0) [<xref rid="coa14257-bib-0015" ref-type="bibr">15</xref>] in R 4.1.3 [<xref rid="coa14257-bib-0016" ref-type="bibr">16</xref>]. Exact matching was used for sex and ethnicity and propensity score&#8208;based nearest neighbour matching for all remaining covariates. This resulted in good balance of all covariates across cases and controls without failing to match any cases (Table&#160;<xref rid="coa14257-supitem-0001" ref-type="supplementary-material">S2</xref>).</p></sec><sec id="coa14257-sec-0018"><label>2.5.2</label><title>Logistic Regressions for Disease&#8208;Disease Associations</title><p>To investigate associations between cholesteatoma and other ICD&#8208;10 codes, we performed pairwise logistic regression on cholesteatoma status against ICD&#8208;10 code presence/absence. ICD&#8208;10 codes were first collapsed to their parent category (e.g., H72.1 becomes H72). Non&#8208;relevant codes were removed, such as those for medications or accidents (codes starting V, X, Y, Z, S, T or R). Presence&#8211;absence of a remaining 1312 ICD&#8208;10 parent codes were tested separately for association with cholesteatoma using the MATLAB <italic toggle="yes">fitglm</italic> function with age and sex as covariates. All <italic toggle="yes">p</italic> values were Bonferroni corrected to adjust for the number of codes tested. Parent codes varied greatly in the number of cases present amongst the full, unmatched data (<italic toggle="yes">n</italic>&#8201;=&#8201;1&#8211;151&#8201;022). All cholesteatoma cases (<italic toggle="yes">n</italic>&#8201;=&#8201;1151) were compared to the full set of controls with and without other ear disease (<italic toggle="yes">n</italic>&#8201;=&#8201;501&#8201;256). Participants with missing smoking data were retained in this analysis.</p></sec><sec id="coa14257-sec-0019"><label>2.5.3</label><title>Cox Hazard Regression for Comparison to <styled-content style="fixed-case" toggle="no">FinnGen</styled-content>
</title><p>The FinnGen comparison data include Cox hazard ratios for ICD&#8208;10 codes before and after cholesteatoma. To compare the UKBB data to FinnGen, we performed Cox hazard regression on the set of codes with significant hazard ratios in FinnGen. UKBB cholesteatoma cases with time to event information (<italic toggle="yes">n</italic>&#8201;=&#8201;650) were compared to ear disease&#8208;free controls (<italic toggle="yes">n</italic>&#8201;=&#8201;496&#8201;667) as in Risteys. Age and sex were used as covariates.</p><p>Figure&#160;<xref rid="coa14257-fig-0001" ref-type="fig">1</xref> shows handling of missing data.</p><fig position="float" fig-type="FIGURE" id="coa14257-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Participant numbers and missingness information for cases and controls. One participant was excluded for missing all covariates. Deprivation was imputed from indices if multiple deprivation (IMD) where available. Where not available, Townsend deprivation index was mean imputed. 2884 cases with missing smoking data were excluded from demographic analysis.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="COA-50-316-g003.jpg"/></fig></sec></sec></sec><sec sec-type="results" id="coa14257-sec-0020"><label>3</label><title>Results</title><sec id="coa14257-sec-0021"><label>3.1</label><title>Descriptive Data</title><sec id="coa14257-sec-0022"><label>3.1.1</label><title>Demographics of Cholesteatoma and Non&#8208;Cholesteatoma Middle Ear Disease</title><p>Total prevalence of cholesteatoma in UKBB was 0.22%, corresponding to approximately 1 in 500 people. Prevalence was higher in males with a male/female ratio of 1:1.35. In comparison, the prevalence in FinnGen was 0.38% with a male/female ratio of 1:1.67. The median age of cholesteatoma and NC&#8208;MED cohorts in UKBB was 73 (IQR&#8201;=&#8201;12 for both), while the median age of controls was 72 (IQR&#8201;=&#8201;13). The median deprivation index of the cholesteatoma cohort was &#8722;1.40 (IQR&#8201;=&#8201;5.14); NC&#8208;MED &#8722;1.70 (IQR&#8201;=&#8201;4.82); and the controls &#8722;2.14 (IQR&#8201;=&#8201;4.18), where the higher scores indicate most deprivation.</p></sec></sec><sec id="coa14257-sec-0023"><label>3.2</label><title>Main Results</title><p>Significant associations with cholesteatoma incidence were found for sex (male AOR&#8201;=&#8201;1.33, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001, 95%CI&#8201;=&#8201;[1.179, 1.491]), deprivation (AOR&#8201;=&#8201;1.08, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001, 95%CI&#8201;=&#8201;[1.059&#8211;1.097]), age (AOR&#8201;=&#8201;1.02, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001, 95%CI&#8201;=&#8201;[1.011, 1.026]), Black ethnicity (AOR&#8201;=&#8201;0.35, <italic toggle="yes">p</italic>&#8201;=&#8201;0.0035, 95%CI&#8201;=&#8201;[0.175, 0.71]) and other/unknown ethnicity (AOR 0.48, <italic toggle="yes">p</italic>&#8201;=&#8201;0.042, 95%CI&#8201;=&#8201;[0.241, 0.973]) (Table&#160;<xref rid="coa14257-tbl-0001" ref-type="table">1</xref>, Figure&#160;<xref rid="coa14257-fig-0002" ref-type="fig">2d</xref>). The ORs obtained in sensitivity analysis for demographic factors generally agreed with the AORs obtained from the unmatched data except for the other/unknown ethnicity, showing that imbalance did not greatly affect the results (Table&#160;<xref rid="coa14257-supitem-0001" ref-type="supplementary-material">S3</xref>).</p><table-wrap position="float" id="coa14257-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Descriptive and inferential statistics of cholesteatoma in the UK Biobank.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th rowspan="2" align="left" valign="bottom" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1"/><th colspan="3" align="center" valign="bottom" rowspan="1">Versus disease&#8208;free controls</th><th colspan="3" align="center" valign="bottom" rowspan="1">Versus other ear disease</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">Prevalence (%)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">N</italic> cases</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">N</italic> total</th><th align="center" valign="bottom" rowspan="1" colspan="1">AOR</th><th align="center" valign="bottom" rowspan="1" colspan="1">95%CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">AOR</th><th align="center" valign="bottom" rowspan="1" colspan="1">95%CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="center" valign="top" rowspan="1" colspan="1">0.22</td><td align="center" valign="top" rowspan="1" colspan="1">1151</td><td align="center" valign="top" rowspan="1" colspan="1">502&#8201;407</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Female</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.20</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>533</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>271&#8201;839</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Male</td><td align="center" valign="top" rowspan="1" colspan="1">0.27</td><td align="center" valign="top" rowspan="1" colspan="1">607</td><td align="center" valign="top" rowspan="1" colspan="1">227&#8201;684</td><td align="center" valign="top" rowspan="1" colspan="1">1.33</td><td align="center" valign="top" rowspan="1" colspan="1">1.179, 1.491</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.30</td><td align="center" valign="top" rowspan="1" colspan="1">1.142, 1.486</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>White</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.23</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>1093</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>470&#8201;982</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mixed</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">2940</td><td align="center" valign="top" rowspan="1" colspan="1">0.000</td><td align="center" valign="top" rowspan="1" colspan="1">0, Inf</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.00</td><td align="center" valign="top" rowspan="1" colspan="1">0, Inf</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Asian</td><td align="center" valign="top" rowspan="1" colspan="1">0.31</td><td align="center" valign="top" rowspan="1" colspan="1">30</td><td align="center" valign="top" rowspan="1" colspan="1">9769</td><td align="center" valign="top" rowspan="1" colspan="1">1.237</td><td align="center" valign="top" rowspan="1" colspan="1">0.857, 1.787</td><td align="center" valign="top" rowspan="1" colspan="1">0.26</td><td align="center" valign="top" rowspan="1" colspan="1">0.84</td><td align="center" valign="top" rowspan="1" colspan="1">0.56, 1.268</td><td align="center" valign="top" rowspan="1" colspan="1">0.41</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Black</td><td align="center" valign="top" rowspan="1" colspan="1">0.10</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">7998</td><td align="center" valign="top" rowspan="1" colspan="1">0.352</td><td align="center" valign="top" rowspan="1" colspan="1">0.175, 0.71</td><td align="center" valign="top" rowspan="1" colspan="1">0.0035</td><td align="center" valign="top" rowspan="1" colspan="1">0.60</td><td align="center" valign="top" rowspan="1" colspan="1">0.28, 1.28</td><td align="center" valign="top" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chinese</td><td align="center" valign="top" rowspan="1" colspan="1">0.06</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1569</td><td align="center" valign="top" rowspan="1" colspan="1">0.287</td><td align="center" valign="top" rowspan="1" colspan="1">0.04, 2.041</td><td align="center" valign="top" rowspan="1" colspan="1">0.21</td><td align="center" valign="top" rowspan="1" colspan="1">0.17</td><td align="center" valign="top" rowspan="1" colspan="1">0.023, 1.283</td><td align="center" valign="top" rowspan="1" colspan="1">0.086</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Other/unknown</td><td align="center" valign="top" rowspan="1" colspan="1">0.13</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">6265</td><td align="center" valign="top" rowspan="1" colspan="1">0.484</td><td align="center" valign="top" rowspan="1" colspan="1">0.241, 0.973</td><td align="center" valign="top" rowspan="1" colspan="1">0.042</td><td align="center" valign="top" rowspan="1" colspan="1">0.45</td><td align="center" valign="top" rowspan="1" colspan="1">0.212, 0.935</td><td align="center" valign="top" rowspan="1" colspan="1">0.033</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Non&#8208;smokers</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.21</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>420</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>200 812</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Smokers</td><td align="center" valign="top" rowspan="1" colspan="1">0.24</td><td align="center" valign="top" rowspan="1" colspan="1">720</td><td align="center" valign="top" rowspan="1" colspan="1">298&#8201;711</td><td align="center" valign="top" rowspan="1" colspan="1">1.06</td><td align="center" valign="top" rowspan="1" colspan="1">0.934, 1.194</td><td align="center" valign="top" rowspan="1" colspan="1">0.38</td><td align="center" valign="top" rowspan="1" colspan="1">0.98</td><td align="center" valign="top" rowspan="1" colspan="1">0.856, 1.128</td><td align="center" valign="top" rowspan="1" colspan="1">0.80</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Deprivation</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#8212;</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#8212;</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">
<bold>1.08</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">1.059, 1.097</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>1.02</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">1.001, 1.042</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.040</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Age</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#8212;</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#8212;</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">
<bold>1.02</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">1.011, 1.026</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>1</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.99, 1.007</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.69</bold>
</td></tr></tbody></table><table-wrap-foot id="coa14257-ntgp-0002"><fn id="coa14257-note-0002"><p>
<italic toggle="yes">Note</italic>: Prevalence and number of cases by demographic is shown alongside the total number of each demographic within the entire UK BioBank cohort. Adjusted odds ratios (AORs) and <italic toggle="yes">p</italic> values acquired from logistic regression of demographic factors on case status compared to a middle ear disease&#8208;free control cohort and a non&#8208;cholesteatoma ear disease cohort are also shown. Bold indicates the comparison category.</p></fn></table-wrap-foot></table-wrap><fig position="float" fig-type="FIGURE" id="coa14257-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Demographics of unmatched cholesteatoma cases, non&#8208;cholesteatoma middle ear disease (NC&#8208;MED) and ear disease&#8208;free controls showing (a) age distributions, (b) sex ratios, (c) smoking status, (d) prevalence of cholesteatoma and non&#8208;cholesteatoma ear disease by ethnicity and (e) Townsend deprivation index distribution. Plots generated in R using ggplot2 package.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="COA-50-316-g001.jpg"/></fig><p>Comparing cholesteatoma to NC&#8208;MED shows a similar male bias with an AOR of 1.30 (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001, 95%CI&#8201;=&#8201;[1.142, 1.486]), meaning the cholesteatoma group differs from NC&#8208;MED about as much as it differs from the controls (AOR&#8201;=&#8201;1.33; Cases vs. control; Figure&#160;<xref rid="coa14257-fig-0002" ref-type="fig">2b</xref>). The cholesteatoma and NC&#8208;MED ear disease cohorts do not differ significantly in age or smoking status (<italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05) (Figure&#160;<xref rid="coa14257-fig-0002" ref-type="fig">2a,c</xref>). Deprivation was significantly associated with cholesteatoma but to a lesser extent than when compared to healthy ears (AOR 1.02, <italic toggle="yes">p</italic>&#8201;=&#8201;0.040, 95%CI&#8201;=&#8201;[1.001, 1.042]) and the NC&#8208;MED group has a more similar distribution of deprivation to the cholesteatoma group than the controls (Figure&#160;<xref rid="coa14257-fig-0002" ref-type="fig">2e</xref>).</p></sec><sec id="coa14257-sec-0024"><label>3.3</label><title>
<styled-content style="fixed-case" toggle="no">ICD</styled-content>&#8208;10 Associations With Cholesteatoma</title><p>Briefly, 56 <styled-content style="fixed-case" toggle="no">ICD</styled-content>&#8208;10 codes were significantly associated with cholesteatoma after Bonferroni multiple testing correction (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05; Table&#160;<xref rid="coa14257-tbl-0002" ref-type="table">2</xref>). Hierarchical clustering of Jaccard distance between these codes reveals two main groups: common conditions, including chronic obstructive pulmonary disease (OR&#8201;=&#8201;2.03, 95%CI&#8201;=&#8201;[1.653, 2.495]), disorders of lipoprotein metabolism and other lipidaemia (OR&#8201;=&#8201;1.48, 95%CI&#8201;=&#8201;[1.28, 1.703]) and gastro&#8208;oesophageal reflux (OR&#8201;=&#8201;1.51, 95%CI&#8201;=&#8201;[1.288, 1.771]); and diseases of the sinuses and middle ear and their complications (Figure&#160;<xref rid="coa14257-fig-0003" ref-type="fig">3</xref>).</p><table-wrap position="float" id="coa14257-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Table of ICD&#8208;10 codes significantly associated with cholesteatoma.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th colspan="2" align="left" valign="bottom" rowspan="1">Code</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">N</italic> with cholesteatoma</th><th align="center" valign="bottom" rowspan="1" colspan="1">Odds ratio</th><th align="center" valign="bottom" rowspan="1" colspan="1">95%CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">Adjusted <italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">% Overlap</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">H66</td><td align="center" valign="top" rowspan="1" colspan="1">Suppurative and unspecified otitis media</td><td align="center" valign="top" rowspan="1" colspan="1">1275</td><td align="center" valign="top" rowspan="1" colspan="1">263</td><td align="center" valign="top" rowspan="1" colspan="1">144.54</td><td align="center" valign="top" rowspan="1" colspan="1">124.259, 168.125</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">12.16</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H72</td><td align="center" valign="top" rowspan="1" colspan="1">Perforation of tympanic membrane</td><td align="center" valign="top" rowspan="1" colspan="1">1504</td><td align="center" valign="top" rowspan="1" colspan="1">193</td><td align="center" valign="top" rowspan="1" colspan="1">76.07</td><td align="center" valign="top" rowspan="1" colspan="1">64.549, 89.646</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">7.84</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H73</td><td align="center" valign="top" rowspan="1" colspan="1">Other disorders of tympanic membrane</td><td align="center" valign="top" rowspan="1" colspan="1">570</td><td align="center" valign="top" rowspan="1" colspan="1">142</td><td align="center" valign="top" rowspan="1" colspan="1">163.63</td><td align="center" valign="top" rowspan="1" colspan="1">133.92 9, 199.912</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">8.99</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H74</td><td align="center" valign="top" rowspan="1" colspan="1">Other disorders of middle ear and mastoid</td><td align="center" valign="top" rowspan="1" colspan="1">695</td><td align="center" valign="top" rowspan="1" colspan="1">219</td><td align="center" valign="top" rowspan="1" colspan="1">242.12</td><td align="center" valign="top" rowspan="1" colspan="1">203.651, 287.867</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">13.46</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H92</td><td align="center" valign="top" rowspan="1" colspan="1">Otalgia and effusion of ear</td><td align="center" valign="top" rowspan="1" colspan="1">911</td><td align="center" valign="top" rowspan="1" colspan="1">126</td><td align="center" valign="top" rowspan="1" colspan="1">78.22</td><td align="center" valign="top" rowspan="1" colspan="1">64.143, 95.383</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">6.51</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H95*</td><td align="center" valign="top" rowspan="1" colspan="1">Postprocedural disorders of ear and mastoid NEC (included in cholesteatoma definition)</td><td align="center" valign="top" rowspan="1" colspan="1">162</td><td align="center" valign="top" rowspan="1" colspan="1">117</td><td align="center" valign="top" rowspan="1" colspan="1">1249.85</td><td align="center" valign="top" rowspan="1" colspan="1">880.243, 1774.661</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">9.78</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H90</td><td align="center" valign="top" rowspan="1" colspan="1">Conductive and sensorineural hearing loss</td><td align="center" valign="top" rowspan="1" colspan="1">2961</td><td align="center" valign="top" rowspan="1" colspan="1">152</td><td align="center" valign="top" rowspan="1" colspan="1">25.81</td><td align="center" valign="top" rowspan="1" colspan="1">21.65, 30.774</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">3.84</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H70*</td><td align="center" valign="top" rowspan="1" colspan="1">Mastoiditis</td><td align="center" valign="top" rowspan="1" colspan="1">181</td><td align="center" valign="top" rowspan="1" colspan="1">153</td><td align="center" valign="top" rowspan="1" colspan="1">2809.55</td><td align="center" valign="top" rowspan="1" colspan="1">1865.538, 4231.256</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H65</td><td align="center" valign="top" rowspan="1" colspan="1">Nonsuppurative otitis media</td><td align="center" valign="top" rowspan="1" colspan="1">1587</td><td align="center" valign="top" rowspan="1" colspan="1">100</td><td align="center" valign="top" rowspan="1" colspan="1">30.80</td><td align="center" valign="top" rowspan="1" colspan="1">24.924, 38.073</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">3.79</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H91</td><td align="center" valign="top" rowspan="1" colspan="1">Other hearing loss</td><td align="center" valign="top" rowspan="1" colspan="1">10&#8201;920</td><td align="center" valign="top" rowspan="1" colspan="1">213</td><td align="center" valign="top" rowspan="1" colspan="1">9.94</td><td align="center" valign="top" rowspan="1" colspan="1">8.514, 11.608</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.80</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H60</td><td align="center" valign="top" rowspan="1" colspan="1">Otitis externa</td><td align="center" valign="top" rowspan="1" colspan="1">1048</td><td align="center" valign="top" rowspan="1" colspan="1">75</td><td align="center" valign="top" rowspan="1" colspan="1">34.97</td><td align="center" valign="top" rowspan="1" colspan="1">27.429, 44.577</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">3.53</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H61</td><td align="center" valign="top" rowspan="1" colspan="1">Other disorders of external ear</td><td align="center" valign="top" rowspan="1" colspan="1">1741</td><td align="center" valign="top" rowspan="1" colspan="1">88</td><td align="center" valign="top" rowspan="1" colspan="1">23.73</td><td align="center" valign="top" rowspan="1" colspan="1">18.972, 29.683</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">3.14</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H93</td><td align="center" valign="top" rowspan="1" colspan="1">Other disorders of ear NEC</td><td align="center" valign="top" rowspan="1" colspan="1">1874</td><td align="center" valign="top" rowspan="1" colspan="1">45</td><td align="center" valign="top" rowspan="1" colspan="1">10.65</td><td align="center" valign="top" rowspan="1" colspan="1">7.875, 14.407</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.51</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">G51</td><td align="center" valign="top" rowspan="1" colspan="1">Facial Nerve disorders</td><td align="center" valign="top" rowspan="1" colspan="1">1848</td><td align="center" valign="top" rowspan="1" colspan="1">42</td><td align="center" valign="top" rowspan="1" colspan="1">10.10</td><td align="center" valign="top" rowspan="1" colspan="1">7.391, 13.793</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.42</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">G00</td><td align="center" valign="top" rowspan="1" colspan="1">Bacterial meningitis NEC</td><td align="center" valign="top" rowspan="1" colspan="1">186</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">41.78</td><td align="center" valign="top" rowspan="1" colspan="1">24.919, 70.056</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.21</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">F17</td><td align="center" valign="top" rowspan="1" colspan="1">Mental and behavioural disorders due to tobacco use</td><td align="center" valign="top" rowspan="1" colspan="1">24&#8201;886</td><td align="center" valign="top" rowspan="1" colspan="1">127</td><td align="center" valign="top" rowspan="1" colspan="1">2.34</td><td align="center" valign="top" rowspan="1" colspan="1">1.942, 2.813</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.49</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">J32</td><td align="center" valign="top" rowspan="1" colspan="1">Chronic sinusitis</td><td align="center" valign="top" rowspan="1" colspan="1">4446</td><td align="center" valign="top" rowspan="1" colspan="1">41</td><td align="center" valign="top" rowspan="1" colspan="1">4.09</td><td align="center" valign="top" rowspan="1" colspan="1">2.993, 5.6</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.74</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H83</td><td align="center" valign="top" rowspan="1" colspan="1">Other diseases of inner ear</td><td align="center" valign="top" rowspan="1" colspan="1">1591</td><td align="center" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">6.04</td><td align="center" valign="top" rowspan="1" colspan="1">3.946, 9.235</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.81</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q16</td><td align="center" valign="top" rowspan="1" colspan="1">Congenital malformations of ear causing impairment of hearing</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">82.05</td><td align="center" valign="top" rowspan="1" colspan="1">28.032, 240.146</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.34</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">G96</td><td align="center" valign="top" rowspan="1" colspan="1">Other disorders of central nervous system</td><td align="center" valign="top" rowspan="1" colspan="1">562</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">9.55</td><td align="center" valign="top" rowspan="1" colspan="1">5.371, 16.968</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.71</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H69</td><td align="center" valign="top" rowspan="1" colspan="1">Other disorders of Eustachian tube</td><td align="center" valign="top" rowspan="1" colspan="1">317</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">12.99</td><td align="center" valign="top" rowspan="1" colspan="1">6.678, 25.288</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.62</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">I10</td><td align="center" valign="top" rowspan="1" colspan="1">Essential (primary) hypertension</td><td align="center" valign="top" rowspan="1" colspan="1">151&#8201;022</td><td align="center" valign="top" rowspan="1" colspan="1">478</td><td align="center" valign="top" rowspan="1" colspan="1">1.53</td><td align="center" valign="top" rowspan="1" colspan="1">1.355, 1.737</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.32</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">J44</td><td align="center" valign="top" rowspan="1" colspan="1">Chronic obstructive pulmonary disease</td><td align="center" valign="top" rowspan="1" colspan="1">21&#8201;261</td><td align="center" valign="top" rowspan="1" colspan="1">103</td><td align="center" valign="top" rowspan="1" colspan="1">2.03</td><td align="center" valign="top" rowspan="1" colspan="1">1.653, 2.495</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.46</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">J45</td><td align="center" valign="top" rowspan="1" colspan="1">Asthma</td><td align="center" valign="top" rowspan="1" colspan="1">47&#8201;150</td><td align="center" valign="top" rowspan="1" colspan="1">172</td><td align="center" valign="top" rowspan="1" colspan="1">1.71</td><td align="center" valign="top" rowspan="1" colspan="1">1.454, 2.013</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.36</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q17</td><td align="center" valign="top" rowspan="1" colspan="1">Other congenital malformations of ear</td><td align="center" valign="top" rowspan="1" colspan="1">42</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">36.73</td><td align="center" valign="top" rowspan="1" colspan="1">11.312, 119.238</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.25</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">G04</td><td align="center" valign="top" rowspan="1" colspan="1">Encephalitis, myelitis and encephalomyelitis</td><td align="center" valign="top" rowspan="1" colspan="1">426</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">8.06</td><td align="center" valign="top" rowspan="1" colspan="1">3.991, 16.26</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.51</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">B96</td><td align="center" valign="top" rowspan="1" colspan="1">Sequelae of other and unspecified infectious and parasitic diseases</td><td align="center" valign="top" rowspan="1" colspan="1">18&#8201;715</td><td align="center" valign="top" rowspan="1" colspan="1">84</td><td align="center" valign="top" rowspan="1" colspan="1">1.92</td><td align="center" valign="top" rowspan="1" colspan="1">1.534, 2.401</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.42</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">J34</td><td align="center" valign="top" rowspan="1" colspan="1">Other disorders of nose and nasal sinuses</td><td align="center" valign="top" rowspan="1" colspan="1">9626</td><td align="center" valign="top" rowspan="1" colspan="1">49</td><td align="center" valign="top" rowspan="1" colspan="1">2.24</td><td align="center" valign="top" rowspan="1" colspan="1">1.68, 2.984</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.46</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">F32</td><td align="center" valign="top" rowspan="1" colspan="1">Other depressive episodes</td><td align="center" valign="top" rowspan="1" colspan="1">29&#8201;778</td><td align="center" valign="top" rowspan="1" colspan="1">110</td><td align="center" valign="top" rowspan="1" colspan="1">1.74</td><td align="center" valign="top" rowspan="1" colspan="1">1.425, 2.114</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.36</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q75</td><td align="center" valign="top" rowspan="1" colspan="1">Other congenital malformations of skull and face bones</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">59.42</td><td align="center" valign="top" rowspan="1" colspan="1">13.526, 261.048</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.17</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">E78</td><td align="center" valign="top" rowspan="1" colspan="1">Disorders of lipoprotein metabolism and other lipidaemias</td><td align="center" valign="top" rowspan="1" colspan="1">77&#8201;039</td><td align="center" valign="top" rowspan="1" colspan="1">262</td><td align="center" valign="top" rowspan="1" colspan="1">1.48</td><td align="center" valign="top" rowspan="1" colspan="1">1.28, 1.703</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.34</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">J47</td><td align="center" valign="top" rowspan="1" colspan="1">Bronchiectasis</td><td align="center" valign="top" rowspan="1" colspan="1">5742</td><td align="center" valign="top" rowspan="1" colspan="1">34</td><td align="center" valign="top" rowspan="1" colspan="1">2.46</td><td align="center" valign="top" rowspan="1" colspan="1">1.741, 3.465</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.50</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">K21</td><td align="center" valign="top" rowspan="1" colspan="1">Gastro&#8208;oesophageal reflux disease</td><td align="center" valign="top" rowspan="1" colspan="1">54&#8201;508</td><td align="center" valign="top" rowspan="1" colspan="1">183</td><td align="center" valign="top" rowspan="1" colspan="1">1.51</td><td align="center" valign="top" rowspan="1" colspan="1">1.288, 1.771</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.33</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">G40</td><td align="center" valign="top" rowspan="1" colspan="1">Epilepsy</td><td align="center" valign="top" rowspan="1" colspan="1">6849</td><td align="center" valign="top" rowspan="1" colspan="1">37</td><td align="center" valign="top" rowspan="1" colspan="1">2.33</td><td align="center" valign="top" rowspan="1" colspan="1">1.674, 3.231</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.46</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">K52</td><td align="center" valign="top" rowspan="1" colspan="1">Other noninfective gastroenteritis and colitis</td><td align="center" valign="top" rowspan="1" colspan="1">25&#8201;678</td><td align="center" valign="top" rowspan="1" colspan="1">96</td><td align="center" valign="top" rowspan="1" colspan="1">1.68</td><td align="center" valign="top" rowspan="1" colspan="1">1.363, 2.074</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td><td align="center" valign="top" rowspan="1" colspan="1">0.36</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">L40</td><td align="center" valign="top" rowspan="1" colspan="1">Psoriasis</td><td align="center" valign="top" rowspan="1" colspan="1">5499</td><td align="center" valign="top" rowspan="1" colspan="1">31</td><td align="center" valign="top" rowspan="1" colspan="1">2.40</td><td align="center" valign="top" rowspan="1" colspan="1">1.68, 3.438</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td><td align="center" valign="top" rowspan="1" colspan="1">0.47</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H68</td><td align="center" valign="top" rowspan="1" colspan="1">Eustachian salpingitis and obstruction</td><td align="center" valign="top" rowspan="1" colspan="1">28</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">33.08</td><td align="center" valign="top" rowspan="1" colspan="1">7.82, 139.896</td><td align="center" valign="top" rowspan="1" colspan="1">0.003</td><td align="center" valign="top" rowspan="1" colspan="1">0.17</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H54</td><td align="center" valign="top" rowspan="1" colspan="1">Visual impairment including blindness</td><td align="center" valign="top" rowspan="1" colspan="1">2813</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">2.92</td><td align="center" valign="top" rowspan="1" colspan="1">1.869, 4.548</td><td align="center" valign="top" rowspan="1" colspan="1">0.003</td><td align="center" valign="top" rowspan="1" colspan="1">0.51</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">N17</td><td align="center" valign="top" rowspan="1" colspan="1">Acute renal failure</td><td align="center" valign="top" rowspan="1" colspan="1">22&#8201;036</td><td align="center" valign="top" rowspan="1" colspan="1">92</td><td align="center" valign="top" rowspan="1" colspan="1">1.69</td><td align="center" valign="top" rowspan="1" colspan="1">1.357, 2.094</td><td align="center" valign="top" rowspan="1" colspan="1">0.003</td><td align="center" valign="top" rowspan="1" colspan="1">0.40</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">B95</td><td align="center" valign="top" rowspan="1" colspan="1">Streptococcus and staphylococcus as the cause of diseases classified to other chapters</td><td align="center" valign="top" rowspan="1" colspan="1">8860</td><td align="center" valign="top" rowspan="1" colspan="1">44</td><td align="center" valign="top" rowspan="1" colspan="1">2.07</td><td align="center" valign="top" rowspan="1" colspan="1">1.529, 2.801</td><td align="center" valign="top" rowspan="1" colspan="1">0.003</td><td align="center" valign="top" rowspan="1" colspan="1">0.44</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">G52</td><td align="center" valign="top" rowspan="1" colspan="1">Disorders of other cranial nerves</td><td align="center" valign="top" rowspan="1" colspan="1">158</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">10.83</td><td align="center" valign="top" rowspan="1" colspan="1">4.005, 29.299</td><td align="center" valign="top" rowspan="1" colspan="1">0.004</td><td align="center" valign="top" rowspan="1" colspan="1">0.31</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H81</td><td align="center" valign="top" rowspan="1" colspan="1">Disorders of vestibular function</td><td align="center" valign="top" rowspan="1" colspan="1">3088</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">2.80</td><td align="center" valign="top" rowspan="1" colspan="1">1.793, 4.359</td><td align="center" valign="top" rowspan="1" colspan="1">0.008</td><td align="center" valign="top" rowspan="1" colspan="1">0.47</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">J18</td><td align="center" valign="top" rowspan="1" colspan="1">Bronchopneumonia, unspecified</td><td align="center" valign="top" rowspan="1" colspan="1">26&#8201;445</td><td align="center" valign="top" rowspan="1" colspan="1">103</td><td align="center" valign="top" rowspan="1" colspan="1">1.61</td><td align="center" valign="top" rowspan="1" colspan="1">1.309, 1.974</td><td align="center" valign="top" rowspan="1" colspan="1">0.008</td><td align="center" valign="top" rowspan="1" colspan="1">0.37</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">L08</td><td align="center" valign="top" rowspan="1" colspan="1">Other local infections of skin and subcutaneous tissue</td><td align="center" valign="top" rowspan="1" colspan="1">3198</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">2.71</td><td align="center" valign="top" rowspan="1" colspan="1">1.759, 4.187</td><td align="center" valign="top" rowspan="1" colspan="1">0.008</td><td align="center" valign="top" rowspan="1" colspan="1">0.49</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">G47</td><td align="center" valign="top" rowspan="1" colspan="1">Sleep disorders</td><td align="center" valign="top" rowspan="1" colspan="1">11&#8201;734</td><td align="center" valign="top" rowspan="1" colspan="1">53</td><td align="center" valign="top" rowspan="1" colspan="1">1.89</td><td align="center" valign="top" rowspan="1" colspan="1">1.43, 2.491</td><td align="center" valign="top" rowspan="1" colspan="1">0.009</td><td align="center" valign="top" rowspan="1" colspan="1">0.41</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q96</td><td align="center" valign="top" rowspan="1" colspan="1">Turner syndrome</td><td align="center" valign="top" rowspan="1" colspan="1">45</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">25.18</td><td align="center" valign="top" rowspan="1" colspan="1">6.078, 104.301</td><td align="center" valign="top" rowspan="1" colspan="1">0.011</td><td align="center" valign="top" rowspan="1" colspan="1">0.17</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">C07</td><td align="center" valign="top" rowspan="1" colspan="1">Malignant neoplasm of parotid gland</td><td align="center" valign="top" rowspan="1" colspan="1">179</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">9.50</td><td align="center" valign="top" rowspan="1" colspan="1">3.519, 25.657</td><td align="center" valign="top" rowspan="1" colspan="1">0.012</td><td align="center" valign="top" rowspan="1" colspan="1">0.30</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">E66</td><td align="center" valign="top" rowspan="1" colspan="1">Obesity</td><td align="center" valign="top" rowspan="1" colspan="1">35&#8201;634</td><td align="center" valign="top" rowspan="1" colspan="1">122</td><td align="center" valign="top" rowspan="1" colspan="1">1.53</td><td align="center" valign="top" rowspan="1" colspan="1">1.267, 1.846</td><td align="center" valign="top" rowspan="1" colspan="1">0.012</td><td align="center" valign="top" rowspan="1" colspan="1">0.33</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">G08</td><td align="center" valign="top" rowspan="1" colspan="1">Intracranial and intraspinal phlebitis and thrombophlebitis</td><td align="center" valign="top" rowspan="1" colspan="1">103</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">13.29</td><td align="center" valign="top" rowspan="1" colspan="1">4.205, 42.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.014</td><td align="center" valign="top" rowspan="1" colspan="1">0.24</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">M19</td><td align="center" valign="top" rowspan="1" colspan="1">Other arthrosis</td><td align="center" valign="top" rowspan="1" colspan="1">45&#8201;012</td><td align="center" valign="top" rowspan="1" colspan="1">150</td><td align="center" valign="top" rowspan="1" colspan="1">1.48</td><td align="center" valign="top" rowspan="1" colspan="1">1.239, 1.757</td><td align="center" valign="top" rowspan="1" colspan="1">0.016</td><td align="center" valign="top" rowspan="1" colspan="1">0.33</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A09</td><td align="center" valign="top" rowspan="1" colspan="1">Other gastroenteritis and colitis of infectious and unspecified origin</td><td align="center" valign="top" rowspan="1" colspan="1">19&#8201;953</td><td align="center" valign="top" rowspan="1" colspan="1">76</td><td align="center" valign="top" rowspan="1" colspan="1">1.66</td><td align="center" valign="top" rowspan="1" colspan="1">1.318, 2.102</td><td align="center" valign="top" rowspan="1" colspan="1">0.025</td><td align="center" valign="top" rowspan="1" colspan="1">0.36</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">G09</td><td align="center" valign="top" rowspan="1" colspan="1">Sequelae of inflammatory diseases of central nervous system</td><td align="center" valign="top" rowspan="1" colspan="1">104</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">11.97</td><td align="center" valign="top" rowspan="1" colspan="1">3.788, 37.821</td><td align="center" valign="top" rowspan="1" colspan="1">0.031</td><td align="center" valign="top" rowspan="1" colspan="1">0.24</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">N39</td><td align="center" valign="top" rowspan="1" colspan="1">Other disorders of urinary system</td><td align="center" valign="top" rowspan="1" colspan="1">38&#8201;025</td><td align="center" valign="top" rowspan="1" colspan="1">128</td><td align="center" valign="top" rowspan="1" colspan="1">1.49</td><td align="center" valign="top" rowspan="1" colspan="1">1.24, 1.798</td><td align="center" valign="top" rowspan="1" colspan="1">0.032</td><td align="center" valign="top" rowspan="1" colspan="1">0.33</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">J31</td><td align="center" valign="top" rowspan="1" colspan="1">Chronic rhinitis, nasopharyngitis and pharyngitis</td><td align="center" valign="top" rowspan="1" colspan="1">1743</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">3.22</td><td align="center" valign="top" rowspan="1" colspan="1">1.862, 5.582</td><td align="center" valign="top" rowspan="1" colspan="1">0.038</td><td align="center" valign="top" rowspan="1" colspan="1">0.45</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">J33</td><td align="center" valign="top" rowspan="1" colspan="1">Nasal polyp</td><td align="center" valign="top" rowspan="1" colspan="1">4670</td><td align="center" valign="top" rowspan="1" colspan="1">26</td><td align="center" valign="top" rowspan="1" colspan="1">2.28</td><td align="center" valign="top" rowspan="1" colspan="1">1.545, 3.374</td><td align="center" valign="top" rowspan="1" colspan="1">0.045</td><td align="center" valign="top" rowspan="1" colspan="1">0.45</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">B38</td><td align="center" valign="top" rowspan="1" colspan="1">Coccidioidomycosis</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">119.72</td><td align="center" valign="top" rowspan="1" colspan="1">12.384, 1157.385</td><td align="center" valign="top" rowspan="1" colspan="1">0.047</td><td align="center" valign="top" rowspan="1" colspan="1">0.09</td></tr></tbody></table><table-wrap-foot id="coa14257-ntgp-0003"><fn id="coa14257-note-0003"><p>
<italic toggle="yes">Note</italic>: Association tests were performed using logistic regression with age and sex as covariates. Codes are collapsed to parent code, and the ICD&#8208;102019 description is given. Codes marked with an asterisk (*) were included in the case definition.</p></fn></table-wrap-foot></table-wrap><fig position="float" fig-type="FIGURE" id="coa14257-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>Heatmap of Jaccard distance between ICD&#8208;10 codes where odds ratio adjusted <italic toggle="yes">p</italic> value for cholesteatoma association &lt;&#8201;0.05. Colour scale indicates Jaccard distance with diagonals coloured blue. Hierarchical clustering using unweighted average distance/UPGMA (left) shows two main groups of disease codes: Common diseases (dark blue, solid) and sinus/middle ear infections with their rare complications (orange, dashed). Table&#160;<xref rid="coa14257-tbl-0002" ref-type="table">2</xref> contains ICD&#8208;10 code full names and statistics for all codes with adjusted <italic toggle="yes">p</italic> value &lt;&#8201;0.05. Codes marked with an asterisk (*) have child codes used in the definition of the case group.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="COA-50-316-g002.jpg"/></fig><p>The strongest associations (all <italic toggle="yes">p</italic> values &lt;&#8201;0.001) were with other disorders of middle ear and mastoid (OR&#8201;=&#8201;242.12, 95%CI&#8201;=&#8201;[203.651, 287.867]), other disorders of tympanic membrane (OR&#8201;=&#8201;163.63, 95%CI&#8201;=&#8201;[133.92 9, 199.912]), suppurative and unspecified otitis media (OR&#8201;=&#8201;144.54, 95%CI&#8201;=&#8201;[124.259, 168.125]), otalgia and effusion of the ear (OR&#8201;=&#8201;78.22, 95%CI&#8201;=&#8201;[64.143, 95.383]) and perforation of the tympanic membrane (OR 76.07, 95%CI&#8201;=&#8201;[64.549, 89.646]). The overlap with cholesteatoma for each of these conditions was 100&#8211;263 persons. Otitis externa (OR&#8201;=&#8201;34.97, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001, 95%CI&#8201;=&#8201;[27.429, 44.577]) and other diseases of inner ear (OR&#8201;=&#8201;6.04, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001, 95%CI&#8201;=&#8201;[3.946, 9.235]) were also associated with cholesteatoma. Known complications of cholesteatoma were also strongly associated, including sensorineural and conductive hearing loss (OR&#8201;=&#8201;25.81, 95%CI&#8201;=&#8201;[21.65, 30.774]), other hearing loss (OR&#8201;=&#8201;9.94, 95%CI&#8201;=&#8201;[8.514, 11.608]), facial nerve disorders (OR&#8201;=&#8201;10.10, 95%CI&#8201;=&#8201;[7.391, 13.793]) and bacterial meningitis (OR&#8201;=&#8201;41.78, 95%CI&#8201;=&#8201;[24.919, 70.056]).</p><p>The most strongly associated non&#8208;ear code not known to be a cholesteatoma complication was F17, mental and behavioural disorders due to tobacco use with an OR of 2.34 (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001, 95%CI&#8201;=&#8201;[1.942, 2.813]), followed by chronic sinusitis, with an OR of 4.09 (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). Several other respiratory conditions are represented including chronic obstructive pulmonary disease, asthma and chronic rhinitis with and without nasal polyps. Some congenital anomalies affecting the ear and head (Q17, Q16, Q75, Q96) were also strongly associated with cholesteatoma (OR&#8201;=&#8201;33.58&#8211;83.24, <italic toggle="yes">p</italic>&#8201;&#8804;&#8201;0.011), although the number of overlapping cases was small (<italic toggle="yes">n</italic>&#8201;=&#8201;2&#8211;4).</p></sec><sec id="coa14257-sec-0025"><label>3.4</label><title>Comparison to <styled-content style="fixed-case" toggle="no">FinnGen</styled-content> Significant Associations</title><p>Diseases occurring before cholesteatoma with significantly increased hazard ratios in both biobanks were otosclerosis and sleep apnoea (Table&#160;<xref rid="coa14257-tbl-0003" ref-type="table">3</xref>). Hazards of otosclerosis, epilepsy and chronic kidney disease were significantly increased after cholesteatoma in both biobanks.</p><table-wrap position="float" id="coa14257-tbl-0003" content-type="TABLE" orientation="portrait"><label>TABLE 3</label><caption><p>Comparison of UKBB odds ratios and hazard ratios to FinnGen.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1"/><th colspan="2" align="center" valign="bottom" rowspan="1">FinnGen</th><th colspan="2" align="center" valign="bottom" rowspan="1">UKBB</th><th colspan="2" align="center" valign="bottom" rowspan="1">UKBB</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">HR [95%CI]</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">OR [95%CI]</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic> (uncorrected)</th><th align="center" valign="bottom" rowspan="1" colspan="1">HR [95%CI]</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td rowspan="4" align="left" valign="top" colspan="1">Before cholesteatoma</td><td align="center" valign="top" rowspan="1" colspan="1">Otosclerosis</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>6.80</p>
<p>[4.14, 11.18]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>5.18</p>
<p>[2.144, 12.552]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>7.98</p>
<p>[7.98, 31.998]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.003</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Sudden idiopathic hearing loss</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>2.93</p>
<p>[1.62, 5.31]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>9.94</p>
<p>[8.514, 11.608]<xref rid="coa14257-note-0005" ref-type="table-fn">
<sup>a</sup>
</xref>
</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>0</p>
<p>[0, 8.65&#8201;&#215;&#8201;10<sup>171</sup>]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.974</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Arthrosis<xref rid="coa14257-note-0006" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>0.72</p>
<p>[0.7, 0.91]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.0062</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">
<p>1.12</p>
<p>[1.12, 1.545]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.974</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Pre&#8208;eclampsia or eclampsia<xref rid="coa14257-note-0007" ref-type="table-fn">
<sup>c</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>1.80</p>
<p>[1.09, 2.96]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.022</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Gonarthrosis</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>0.71</p>
<p>[0.53, 0.96]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.025</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>0.98</p>
<p>[0.796, 1.215]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.87</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>0.78</p>
<p>[0.78, 1.327]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.356</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Coxarthrosis</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>0.59</p>
<p>[0.37, 0.93]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.025</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>0.96</p>
<p>[0.739, 1.259]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.79</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>0.88</p>
<p>[0.88, 1.711]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.708</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Sleep apnoea</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>1.38</p>
<p>[1.04, 1.83]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.028</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>1.88</p>
<p>[1.43, 2.491]<xref rid="coa14257-note-0008" ref-type="table-fn">
<sup>d</sup>
</xref>
</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>2.1</p>
<p>[2.1, 4.065]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.029</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Pain<xref rid="coa14257-note-0009" ref-type="table-fn">
<sup>e</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>1.18</p>
<p>[1.01, 1.38]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.036</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td rowspan="6" align="left" valign="top" colspan="1">After cholesteatoma</td><td align="center" valign="top" rowspan="1" colspan="1">Otosclerosis</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>6.06</p>
<p>[3.41, 10.76]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>5.18</p>
<p>[2.144, 12.552]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>8.7</p>
<p>[8.7, 34.952]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Vascular dementia</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>5.02</p>
<p>[2.36, 10.68]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>3.66</p>
<p>[0.217, 2.105]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.19</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>0.93</p>
<p>[0.93, 3.737]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.923</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Epilepsy</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>1.79</p>
<p>[1.09, 2.93]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.021</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>1.47</p>
<p>[1.869, 4.548]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>2.85</p>
<p>[2.85, 4.733]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;&#8201;0.001</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Chronic kidney disease</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>1.77</p>
<p>[1.08, 2.92]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.025</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>1.43</p>
<p>[1.119, 1.812]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.0041</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>1.5</p>
<p>[1.5, 2.09]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.017</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Iron deficiency anaemia</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>1.74</p>
<p>[1.07, 2.82]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.026</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>1.44</p>
<p>[1.136, 1.829]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.0027</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>1.17</p>
<p>[1.17, 1.746]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.441</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Varicose veins</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>0.59</p>
<p>[0.35, 0.98]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.041</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>1.061</p>
<p>[0.776, 1.45]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.71</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>1.01</p>
<p>[1.01, 1.885]</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.964</td></tr></tbody></table><table-wrap-foot id="coa14257-ntgp-0004"><fn id="coa14257-note-0004"><p>
<italic toggle="yes">Note</italic>: Table showing Cox hazard ratios computed by Risteys from FinnGen data where <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05 and equivalent Cox hazard ratios and <italic toggle="yes">p</italic> values computed for UKBB data. Also shown are the uncorrected <italic toggle="yes">p</italic> values and odds ratios drawn from logistic regressions for the closest equivalent ICD&#8208;10 codes. Risteys phenotypes are as follows.</p></fn><fn id="coa14257-note-0005"><label>
<sup>a</sup>
</label><p>Showing H91 for UKBB OR, parent code of sudden idiopathic hearing loss (H91.2).</p></fn><fn id="coa14257-note-0006"><label>
<sup>b</sup>
</label><p>Arthrosis combines parent categories M15&#8208;M19.</p></fn><fn id="coa14257-note-0007"><label>
<sup>c</sup>
</label><p>Combination of eclampsia (O15) and pre&#8208;eclampsia (O14). No overlap with cases in UKBB.</p></fn><fn id="coa14257-note-0008"><label>
<sup>d</sup>
</label><p>Showing G47 for UKBB OR, parent code of sleep apnoea (G47.3).</p></fn><fn id="coa14257-note-0009"><label>
<sup>e</sup>
</label><p>Hybrid category of several ICD&#8208;10 codes involving pain in FinnGen, not tested in UKBB.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion" id="coa14257-sec-0026"><label>4</label><title>Discussion</title><sec id="coa14257-sec-0027"><label>4.1</label><title>Key Results</title><p>Here we present an epidemiological study of cholesteatoma in the UKBB to establish demographic factors associated with cholesteatoma in this cohort and to identify associated diseases using ICD&#8208;10 codes. We also compared these results with summary analyses performed on data from the Finnish biobank FinnGen. Our study replicated some demographic risk factors for cholesteatoma identified in previous studies. We also found a large overlap between cholesteatoma and other middle ear diseases, and the demographics of these groups are similar except for sex and ethnicity.</p></sec><sec id="coa14257-sec-0028"><label>4.2</label><title>Associations With Sex, Deprivation and Smoking</title><p>Male sex was an important risk factor for cholesteatoma compared to disease&#8208;free controls (AOR&#8201;=&#8201;1.33, 95%CI&#8201;=&#8201;[1.179&#8211;1.491]). A male predominance is well established in the literature and the sex ratios of 1:13 females to males in UKBB and 1:1.67 in FinnGen are similar to the reported range [<xref rid="coa14257-bib-0002" ref-type="bibr">2</xref>, <xref rid="coa14257-bib-0017" ref-type="bibr">17</xref>]. Both cholesteatoma and NC&#8208;MED were associated with higher deprivation, with cholesteatoma associated with the highest deprivation (median&#8201;&#8722;&#8201;1.40, &#8722;1.70 and &#8722;2.14, respectively). Deprivation is associated with risk behaviours such as smoking [<xref rid="coa14257-bib-0018" ref-type="bibr">18</xref>, <xref rid="coa14257-bib-0019" ref-type="bibr">19</xref>], and the most disadvantaged are both more likely to require healthcare and less likely to access it [<xref rid="coa14257-bib-0020" ref-type="bibr">20</xref>]. These factors may contribute to greater rates of ear disease and cholesteatoma. However, it is also possible that increased deprivation results from cholesteatoma due to the economic impact of hearing loss. Increased odds of several common diseases found in this study may also reflect generally poorer health in the cholesteatoma group. Meanwhile, the odds ratio associated with age for both cholesteatoma and NC&#8208;MED is likely due to older participants having had longer to develop any disease.</p><p>Rates of cholesteatoma have also been reported to vary with ethnicity [<xref rid="coa14257-bib-0001" ref-type="bibr">1</xref>], although original epidemiological data is rarely presented. Both rates of cholesteatoma and NC&#8208;MED varied between ethnicities in this analysis, although the only consistent significant difference was for the Black ethnicity, who had reduced odds of both cholesteatoma and NC&#8208;MED. The Chinese and Asian groups also had increased odds of NC&#8208;MED, but the sample sizes may have been too small to properly quantify their risk of cholesteatoma.</p><p>Although smoking was not significantly associated with cholesteatoma according to the survey results, the disease code F17 mental and behavioural disorders due to use of tobacco was (OR 2.34, 95%CI&#8201;=&#8201;[1.942, 2.813]). This suggests that infrequent or discontinued smoking affects risk of cholesteatoma less than heavy smoking. This confirms the results of Kaylie et&#160;al. [<xref rid="coa14257-bib-0008" ref-type="bibr">8</xref>], where they found a higher rate of cholesteatoma and more severe disease in smokers with chronic ear problems, but that former smokers had similar outcomes to non&#8208;smokers &gt;&#8201;5&#8201;years after smoking cessation. Smoking may increase susceptibility to ear disease by impairing mucociliary function [<xref rid="coa14257-bib-0008" ref-type="bibr">8</xref>], which may also impact cholesteatoma risk.</p></sec><sec id="coa14257-sec-0029"><label>4.3</label><title>Sex Distinguishes Cholesteatoma From Other Middle Ear Disease</title><p>A key finding was that the cholesteatoma and NC&#8208;MED cohorts were more similar to each other than the controls on several characteristics. Sex ratio was a key difference distinguishing cholesteatoma from NC&#8208;MED, with the AOR for cholesteatoma being similar when compared to NC&#8208;MED or controls (AOR&#8201;=&#8201;1.3 vs. NC&#8208;MED; AOR&#8201;=&#8201;1.33 vs. controls). Furthermore, sex ratio did not differ significantly between middle ear disease and the control group (<italic toggle="yes">p</italic>&#8201;=&#8201;0.49; Table&#160;<xref rid="coa14257-supitem-0001" ref-type="supplementary-material">S4</xref>). This means that either males are not at increased risk of general ear disease, only of cholesteatoma; or that they are at increased risk of all forms of ear disease and at increased risk of sequelae, including cholesteatoma.</p></sec><sec id="coa14257-sec-0030"><label>4.4</label><title>Cholesteatoma Is Significantly Associated With Other Inflammatory Ear and Respiratory Disease</title><p>In this study, we found a large overlap between the incidence of cholesteatoma and other middle ear disease. Many of these are likely consequences of cholesteatoma or related ear conditions, such as hearing loss, otorrhoea, tympanic perforation, mastoiditis, Eustachian tube disorders and several forms of otitis media. A history of ear disease, including chronic otitis media is well&#8208;established risk factors in cholesteatoma: Kemppainen et&#160;al. [<xref rid="coa14257-bib-0002" ref-type="bibr">2</xref>] report history of otitis in 72.4% of cases, and Castle [<xref rid="coa14257-bib-0021" ref-type="bibr">21</xref>] reports common concurrent diseases including otic polyp and tympanosclerosis. Whether inflammation precedes cholesteatoma or is a symptom of it cannot be determined from this study design. However, children with repeated ear infection requiring ventilation tube insertion are at increased risk of cholesteatoma [<xref rid="coa14257-bib-0022" ref-type="bibr">22</xref>], implying that increased susceptibility to middle ear infection also increases cholesteatoma susceptibility, either directly or because both result from poor ear ventilation. Tympanic retraction is also a risk factor for cholesteatoma, though most retractions do not progress to cholesteatoma [<xref rid="coa14257-bib-0023" ref-type="bibr">23</xref>].</p><p>This study also found an association between cholesteatoma and chronic respiratory inflammation including rhinosinusitis and asthma. Chronic sinusitis may impact Eustachian tube function and ventilation of the middle ear, possibly contributing to cholesteatoma risk, or this may represent a general susceptibility to chronic inflammation of the airways.</p><p>Increased hazards of otosclerosis both before cholesteatoma in UKBB and FinnGen is a surprising finding as the co&#8208;occurrence of these conditions is extremely rarely reported [<xref rid="coa14257-bib-0024" ref-type="bibr">24</xref>]. Otosclerosis is a disease of the labyrinth resulting from remodelling and overgrowth of the bone at the base of the stapes [<xref rid="coa14257-bib-0025" ref-type="bibr">25</xref>]. Though it is possible that a background of inflammation in the middle ear could increase risk of otosclerosis, these conditions rarely occur together and can easily be misdiagnosed. Because of the small number of overlapping cases (<italic toggle="yes">n</italic>&#8201;=&#8201;5 in UKBB, 48 in FinnGen), this may be the cause of this association.</p></sec><sec id="coa14257-sec-0031"><label>4.5</label><title>Known Complications of Cholesteatoma and a New Potential Association</title><p>We detected known rare complications of cholesteatoma such as facial nerve disorders (including Bell's palsy) and bacterial meningitis [<xref rid="coa14257-bib-0026" ref-type="bibr">26</xref>]. Similarly, other diseases of the nervous system such as encephalitis, myelitis and encephalomyelitis, and sequelae of inflammatory diseases of the central nervous system may also represent rare complications of cholesteatoma, which occur when the cyst erodes through the temporal bone. The risk of epilepsy following cholesteatoma was also significantly increased in both UKBB and FinnGen. Some of these cases could be a complication of cholesteatoma where there is intracranial involvement, and epilepsy has occasionally been described in this context&#160;[<xref rid="coa14257-bib-0027" ref-type="bibr">27</xref>, <xref rid="coa14257-bib-0028" ref-type="bibr">28</xref>]. Alternatively, epilepsy itself may be a risk factor, as it is often associated with a high burden of comorbid disease [<xref rid="coa14257-bib-0029" ref-type="bibr">29</xref>].</p><p>We also detected increased odds of psoriasis and other local infections of skin and subcutaneous tissue with cholesteatoma. Cholesteatoma expresses several proteins, which are markers of inflammatory skin conditions, including members of the S100 protein family [<xref rid="coa14257-bib-0030" ref-type="bibr">30</xref>].</p></sec><sec id="coa14257-sec-0032"><label>4.6</label><title>Study Limitations</title><p>The limitations of this study reflect the limitations of BioBank&#8208;based observational studies. UKBB is biassed towards females, participants are wealthier and have fewer health conditions than the general population and is majority of white European background [<xref rid="coa14257-bib-0031" ref-type="bibr">31</xref>]. It is also likely that not all cholesteatoma cases could be identified due to the lack of ICD&#8208;10 data prior to its introduction in 1995. We mitigated this by including likely cholesteatoma cases from related ICD&#8208;10 and operative codes, but there are probably still missing cases, including childhood disease. Furthermore, no distinction has been made between congenital and acquired cholesteatoma in this study as they are impossible to distinguish from ICD codes.</p><p>Demographics such as deprivation were collected at the time of recruitment and may differ from the time of disease onset. Additionally, deprivation is based on postcode and may not reflect the status of the individual. Different demographic groups may also differ in their willingness to engage with a doctor, which will influence the apparent effect of these factors.</p><p>Numbers of cases and controls were highly imbalanced. To retain as much information as possible, unmatched controls were used for each analysis which can inflate <italic toggle="yes">p</italic> values. We performed sensitivity analysis for the demographic features using 1:5 matched controls to check that the effect of imbalance was not too severe. However, some ICD&#8208;10 codes have even more extreme imbalance so should be interpreted with caution.</p><p>Conclusions about causality cannot be drawn from observational associations, for example, deprivation could be a sequela or a risk factor for the morbidity associated with cholesteatoma. Time to event information also reflects time of diagnosis, not necessarily the order of disease onset.</p></sec></sec><sec sec-type="conclusions" id="coa14257-sec-0033"><label>5</label><title>Conclusions</title><p>An increased risk of cholesteatoma is associated with male sex, older age and greater deprivation. There is a significant association between cholesteatoma and mental and behavioural disorders due to tobacco use, supporting heavy smoking as a risk factor. Although this study provides evidence of a higher incidence in white compared to non&#8208;white populations, the sample size for non&#8208;white ethnicities in the UKBB is too small to be conclusive.</p><p>Associations are shared between cholesteatoma and other inflammatory middle ear disease, but male sex was a major risk factor distinguishing these groups. Cholesteatoma overlaps significantly with other inflammatory middle ear conditions, but it is difficult to disentangle the factors contributing to ear disease in general from those contributing to cholesteatoma alone. Cholesteatoma was also positively associated with epilepsy and negatively associated with arthrosis in two biobanks. These relationships are unexplored in the literature and warrant further investigation.</p><p>Future studies of cholesteatoma should carefully consider their choice of control population (with middle ear disease or disease&#8208;free ears), as such studies may address different questions about the epidemiology, genetics and pathology of cholesteatoma. This will enhance the ability to discover new risk factors and pathological features and shed further light on an otherwise poorly understood but important cause of hearing loss.</p></sec><sec id="coa14257-sec-0034"><title>Author Contributions</title><p>
<bold>Barbara Anne Jennings, Carl M. Philpott, Peter Prinsley, and Daniel S. Brewer:</bold> conceptualization, funding acquisition, methodology, writing &#8211; review and editing (equal co&#8208;authors). <bold>Mizanur Khondoker:</bold> methodology and statistical supervision, writing &#8211; review and editing (equal co&#8208;authors). <bold>Emma Wilson:</bold> methodology and statistical analysis, investigation and formal analysis (lead), writing &#8211; original draft and editing (lead).</p></sec><sec id="coa14257-sec-0036"><title>Ethics Statement</title><p>UK Biobank has obtained Research Tissue Bank (RTB) approval from its ethics committee that covers our use of downloaded data. The Research Ethics Committee (REC) approval number for UK Biobank is 16/NW/0274.</p></sec><sec sec-type="COI-statement" id="coa14257-sec-0037"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec id="coa14257-sec-0038"><sec disp-level="2" id="coa14257-sec-0040"><title>Peer Review</title><p>The peer review history for this article is available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/coa.14257" ext-link-type="uri">https://www.webofscience.com/api/gateway/wos/peer&#8208;review/10.1111/coa.14257</ext-link>.</p></sec></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="coa14257-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Data S1.</bold> Supporting Information.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="COA-50-316-s002.docx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="coa14257-supitem-0002" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Data S2.</bold> Supporting Information.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="COA-50-316-s001.zip" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="coa14257-sec-0035"><title>Acknowledgements</title><p>Thank you to the University of East Anglia Faculty of Medicine and Health Sciences, who funded the PhD studentship associated with this project. We would also like to thank the Bernice Bibby Research trust for their funding for the wider Genetics of Cholesteatoma project. We would also like to acknowledge the participants and researchers of the UK BioBank and FinnGen studies, whose generous contributions have made this research possible. DSB acknowledges support received for the UEA Cancer Genetics team from Prostate Cancer Research, Prostate Cancer UK, Big C, and the Bob Champion Cancer Trust.</p></ack><sec sec-type="data-availability" id="coa14257-sec-0039"><title>Data Availability Statement</title><p>The data that support the findings of this study are available in UK BioBank after registering for access: (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ukbiobank.ac.uk/enable-your-research/register" ext-link-type="uri" specific-use="software is-supplemented-by">https://www.ukbiobank.ac.uk/enable&#8208;your&#8208;research/register</ext-link>). Publicly available demographic data and statistical results from FinnGen release 9 can be accessed via Risteys (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://r9.risteys.finngen.fi/endpoints/H8_CHOLEASTOMA" ext-link-type="uri" specific-use="software is-supplemented-by">https://r9.risteys.finngen.fi/endpoints/H8_CHOLEASTOMA</ext-link>).</p></sec><ref-list content-type="cited-references" id="coa14257-bibl-0001"><title>References</title><ref id="coa14257-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="coa14257-cit-0001"><string-name name-style="western"><given-names>E.</given-names><surname>Olszewska</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Wagner</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Bernal&#8208;Sprekelsen</surname></string-name>, et&#160;al., &#8220;<article-title>Etiopathogenesis of Cholesteatoma</article-title>,&#8221; <source>European Archives of Oto&#8208;Rhino&#8208;Laryngology and Head &amp; Neck</source><volume>261</volume>, no. <issue>1</issue> (<year>2004</year>): <fpage>6</fpage>&#8211;<lpage>24</lpage>, <pub-id pub-id-type="doi">10.1007/s00405-003-0623-x</pub-id>.<pub-id pub-id-type="pmid">12835944</pub-id></mixed-citation></ref><ref id="coa14257-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="coa14257-cit-0002"><string-name name-style="western"><given-names>H. O.</given-names><surname>Kemppainen</surname></string-name>, <string-name name-style="western"><given-names>H. J.</given-names><surname>Puhakka</surname></string-name>, <string-name name-style="western"><given-names>P. J.</given-names><surname>Laippala</surname></string-name>, <string-name name-style="western"><given-names>M. S.</given-names><surname>Markku</surname></string-name>, <string-name name-style="western"><given-names>P. M.</given-names><surname>Mikko</surname></string-name>, and <string-name name-style="western"><given-names>H. K.</given-names><surname>Pekka</surname></string-name>, &#8220;<article-title>Epidemiology and Aetiology of Middle Ear Cholesteatoma</article-title>,&#8221; <source>Acta Oto&#8208;Laryngologica</source><volume>119</volume>, no. <issue>5</issue> (<year>1999</year>): <fpage>568</fpage>&#8211;<lpage>572</lpage>, <pub-id pub-id-type="doi">10.1080/00016489950180801</pub-id>.<pub-id pub-id-type="pmid">10478597</pub-id></mixed-citation></ref><ref id="coa14257-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="coa14257-cit-0003"><string-name name-style="western"><given-names>R.</given-names><surname>Collins</surname></string-name>, <string-name name-style="western"><given-names>N. H.</given-names><surname>Ta</surname></string-name>, <string-name name-style="western"><given-names>B. A.</given-names><surname>Jennings</surname></string-name>, et&#160;al., &#8220;<article-title>Cholesteatoma and Family History: An International Survey</article-title>,&#8221; <source>Clinical Otolaryngology</source><volume>45</volume>, no. <issue>4</issue> (<year>2020</year>): <fpage>500</fpage>&#8211;<lpage>505</lpage>, <pub-id pub-id-type="doi">10.1111/coa.13544</pub-id>.<pub-id pub-id-type="pmid">32271986</pub-id></mixed-citation></ref><ref id="coa14257-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="coa14257-cit-0004"><string-name name-style="western"><given-names>&#197;.</given-names><surname>Bonnard</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Engm&#233;r Berglin</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Wincent</surname></string-name>, et&#160;al., &#8220;<article-title>The Risk of Cholesteatoma in Individuals With First&#8208;Degree Relatives Surgically Treated for the Disease</article-title>,&#8221; <source>Journal of the American Medical Association (JAMA) Otolaryngology. Head &amp; Neck Surgery</source><volume>149</volume>, no. <issue>5</issue> (<year>2023</year>): <fpage>390</fpage>&#8211;<lpage>396</lpage>, <pub-id pub-id-type="doi">10.1001/jamaoto.2023.0048</pub-id>.<pub-id pub-id-type="pmcid">PMC10020932</pub-id><pub-id pub-id-type="pmid">36929420</pub-id></mixed-citation></ref><ref id="coa14257-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="coa14257-cit-0005"><string-name name-style="western"><given-names>B. A.</given-names><surname>Jennings</surname></string-name>, <string-name name-style="western"><given-names>P.</given-names><surname>Prinsley</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Philpott</surname></string-name>, <string-name name-style="western"><given-names>G.</given-names><surname>Willis</surname></string-name>, and <string-name name-style="western"><given-names>M. F.</given-names><surname>Bhutta</surname></string-name>, &#8220;<article-title>The Genetics of Cholesteatoma. A Systematic Review Using Narrative Synthesis</article-title>,&#8221; <source>Clinical Otolaryngology</source><volume>43</volume>, no. <issue>1</issue> (<year>2018</year>): <fpage>55</fpage>&#8211;<lpage>67</lpage>, <pub-id pub-id-type="doi">10.1111/coa.12900</pub-id>.<pub-id pub-id-type="pmid">28485112</pub-id></mixed-citation></ref><ref id="coa14257-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="coa14257-cit-0006"><string-name name-style="western"><given-names>M.</given-names><surname>Khalid&#8208;Raja</surname></string-name>, <string-name name-style="western"><given-names>T.</given-names><surname>Tikka</surname></string-name>, and <string-name name-style="western"><given-names>C.</given-names><surname>Coulson</surname></string-name>, &#8220;<article-title>Cholesteatoma: A Disease of the Poor (Socially Deprived)?</article-title>,&#8221; <source>European Archives of Oto&#8208;Rhino&#8208;Laryngology</source><volume>272</volume>, no. <issue>10</issue> (<year>2015</year>): <fpage>2799</fpage>&#8211;<lpage>2805</lpage>, <pub-id pub-id-type="doi">10.1007/s00405-014-3285-y</pub-id>.<pub-id pub-id-type="pmid">25231708</pub-id></mixed-citation></ref><ref id="coa14257-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="coa14257-cit-0007"><string-name name-style="western"><given-names>D.</given-names><surname>Thornton</surname></string-name>, <string-name name-style="western"><given-names>T. P. C.</given-names><surname>Martin</surname></string-name>, <string-name name-style="western"><given-names>P.</given-names><surname>Amin</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Haque</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Wilson</surname></string-name>, and <string-name name-style="western"><given-names>M. C. F.</given-names><surname>Smith</surname></string-name>, &#8220;<article-title>Chronic Suppurative Otitis Media in Nepal: Ethnicity Does Not Determine Whether Disease Is Associated With Cholesteatoma or Not</article-title>,&#8221; <source>Journal of Laryngology and Otology</source><volume>125</volume>, no. <issue>1</issue> (<year>2011</year>): <fpage>22</fpage>&#8211;<lpage>26</lpage>, <pub-id pub-id-type="doi">10.1017/S0022215110001878</pub-id>.<pub-id pub-id-type="pmid">20875194</pub-id></mixed-citation></ref><ref id="coa14257-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="coa14257-cit-0008"><string-name name-style="western"><given-names>D. M.</given-names><surname>Kaylie</surname></string-name>, <string-name name-style="western"><given-names>M. L.</given-names><surname>Bennett</surname></string-name>, <string-name name-style="western"><given-names>B.</given-names><surname>Davis</surname></string-name>, and <string-name name-style="western"><given-names>C. G.</given-names><surname>Jackson</surname></string-name>, &#8220;<article-title>Effects of Smoking on Otologic Surgery Outcomes</article-title>,&#8221; <source>Laryngoscope</source><volume>119</volume>, no. <issue>7</issue> (<year>2009</year>): <fpage>1384</fpage>&#8211;<lpage>1390</lpage>, <pub-id pub-id-type="doi">10.1002/lary.20256</pub-id>.<pub-id pub-id-type="pmid">19418530</pub-id></mixed-citation></ref><ref id="coa14257-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="coa14257-cit-0009"><string-name name-style="western"><given-names>J.</given-names><surname>Nevoux</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Lenoir</surname></string-name>, <string-name name-style="western"><given-names>G.</given-names><surname>Roger</surname></string-name>, <string-name name-style="western"><given-names>F.</given-names><surname>Denoyelle</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Ducou Le Pointe</surname></string-name>, and <string-name name-style="western"><given-names>E. N.</given-names><surname>Garab&#233;dian</surname></string-name>, &#8220;<article-title>Childhood Cholesteatoma</article-title>,&#8221; <source>European Annals of Otorhinolaryngology, Head and Neck Diseases</source><volume>127</volume>, no. <issue>4</issue> (<year>2010</year>): <fpage>143</fpage>&#8211;<lpage>150</lpage>, <pub-id pub-id-type="doi">10.1016/j.anorl.2010.07.001</pub-id>.<pub-id pub-id-type="pmid">20860924</pub-id></mixed-citation></ref><ref id="coa14257-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="coa14257-cit-0010"><string-name name-style="western"><given-names>P.</given-names><surname>Ratnesar</surname></string-name>, &#8220;<article-title>Chronic Ear Disease Along the Coasts of Labrador and Northern Newfoundland</article-title>,&#8221; <source>Journal of Otolaryngology</source><volume>5</volume>, no. <issue>2</issue> (<year>1976</year>): <fpage>122</fpage>&#8211;<lpage>130</lpage>.<pub-id pub-id-type="pmid">933236</pub-id></mixed-citation></ref><ref id="coa14257-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="coa14257-cit-0011"><string-name name-style="western"><given-names>C. L.</given-names><surname>Kuo</surname></string-name>, <string-name name-style="western"><given-names>A. S.</given-names><surname>Shiao</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Yung</surname></string-name>, et&#160;al., &#8220;<article-title>Updates and Knowledge Gaps in Cholesteatoma Research</article-title>,&#8221; <source>BioMed Research International</source><volume>2015</volume> (<year>2015</year>): <elocation-id>854024</elocation-id>, <pub-id pub-id-type="doi">10.1155/2015/854024</pub-id>.<pub-id pub-id-type="pmid">25866816</pub-id><pub-id pub-id-type="pmcid">PMC4381684</pub-id></mixed-citation></ref><ref id="coa14257-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="coa14257-cit-0012"><string-name name-style="western"><given-names>C.</given-names><surname>Bycroft</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Freeman</surname></string-name>, <string-name name-style="western"><given-names>D.</given-names><surname>Petkova</surname></string-name>, et&#160;al., &#8220;<article-title>The UK Biobank Resource With Deep Phenotyping and Genomic Data</article-title>,&#8221; <source>Nature</source><volume>562</volume>, no. <issue>7726</issue> (<year>2018</year>): <fpage>203</fpage>&#8211;<lpage>209</lpage>, <pub-id pub-id-type="doi">10.1038/s41586-018-0579-z</pub-id>.<pub-id pub-id-type="pmid">30305743</pub-id><pub-id pub-id-type="pmcid">PMC6786975</pub-id></mixed-citation></ref><ref id="coa14257-bib-0013"><label>13</label><mixed-citation publication-type="book" id="coa14257-cit-0013"><string-name name-style="western"><given-names>P.</given-names><surname>Townsend</surname></string-name>, <string-name name-style="western"><given-names>P.</given-names><surname>Phillimore</surname></string-name>, and <string-name name-style="western"><given-names>A.</given-names><surname>Beattie</surname></string-name>, <source>Health and Deprivation: Inequality and the North</source> (<publisher-loc>London</publisher-loc>: <publisher-name>Croom Helm</publisher-name>, <year>1988</year>).</mixed-citation></ref><ref id="coa14257-bib-0014"><label>14</label><mixed-citation publication-type="miscellaneous" id="coa14257-cit-0014"><collab collab-type="authors">The MathWorks Inc</collab>
, <article-title>&#8220;MATLAB,&#8221;</article-title> 2022, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mathworks.com" ext-link-type="uri">https://www.mathworks.com</ext-link>.</mixed-citation></ref><ref id="coa14257-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="coa14257-cit-0015"><string-name name-style="western"><given-names>D. E.</given-names><surname>Ho</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Imai</surname></string-name>, <string-name name-style="western"><given-names>G.</given-names><surname>King</surname></string-name>, and <string-name name-style="western"><given-names>E. A.</given-names><surname>Stuart</surname></string-name>, &#8220;<article-title>MatchIt: Nonparametric Preprocessing for Parametric Causal Inference</article-title>,&#8221; <source>Journal of Statistical Software</source><volume>42</volume>, no. <issue>8</issue> (<year>2011</year>): <fpage>1</fpage>&#8211;<lpage>28</lpage>, <pub-id pub-id-type="doi">10.18637/jss.v042.i08</pub-id>.</mixed-citation></ref><ref id="coa14257-bib-0016"><label>16</label><mixed-citation publication-type="miscellaneous" id="coa14257-cit-0016"><collab collab-type="authors">R Core Team</collab>
, <article-title>&#8220;R: A Language and Environment for Statistical Computing,&#8221;</article-title> 2022, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.r-project.or" ext-link-type="uri">https://www.R&#8208;project.or</ext-link>.</mixed-citation></ref><ref id="coa14257-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="coa14257-cit-0017"><string-name name-style="western"><given-names>B. D.</given-names><surname>Djurhuus</surname></string-name>, <string-name name-style="western"><given-names>C. E.</given-names><surname>Faber</surname></string-name>, and <string-name name-style="western"><given-names>A.</given-names><surname>Skytthe</surname></string-name>, &#8220;<article-title>Decreasing Incidence Rate for Surgically Treated Middle Ear Cholesteatoma in Denmark 1977&#8211;2007</article-title>,&#8221; <source>Danish Medical Bulletin</source><volume>57</volume>, no. <issue>10</issue> (<year>2010</year>): <elocation-id>A4186</elocation-id>.<pub-id pub-id-type="pmid">21040679</pub-id></mixed-citation></ref><ref id="coa14257-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="coa14257-cit-0018"><string-name name-style="western"><given-names>M. A.</given-names><surname>Bellis</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Hughes</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Nicholls</surname></string-name>, <string-name name-style="western"><given-names>N.</given-names><surname>Sheron</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>Gilmore</surname></string-name>, and <string-name name-style="western"><given-names>L.</given-names><surname>Jones</surname></string-name>, &#8220;<article-title>The Alcohol Harm Paradox: Using a National Survey to Explore How Alcohol May Disproportionately Impact Health in Deprived Individuals</article-title>,&#8221; <source>BMC Public Health</source><volume>16</volume>, no. <issue>1</issue> (<year>2016</year>): <fpage>111</fpage>, <pub-id pub-id-type="doi">10.1186/s12889-016-2766-x</pub-id>.<pub-id pub-id-type="pmid">26888538</pub-id><pub-id pub-id-type="pmcid">PMC4758164</pub-id></mixed-citation></ref><ref id="coa14257-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="coa14257-cit-0019"><string-name name-style="western"><given-names>H. M. E.</given-names><surname>Foster</surname></string-name>, <string-name name-style="western"><given-names>C. A.</given-names><surname>Celis&#8208;Morales</surname></string-name>, <string-name name-style="western"><given-names>B. I.</given-names><surname>Nicholl</surname></string-name>, et&#160;al., &#8220;<article-title>The Effect of Socioeconomic Deprivation on the Association Between an Extended Measurement of Unhealthy Lifestyle Factors and Health Outcomes: A Prospective Analysis of the UK Biobank Cohort</article-title>,&#8221; <source>Lancet Public Health</source><volume>3</volume>, no. <issue>12</issue> (<year>2018</year>): <fpage>e576</fpage>&#8211;<lpage>e585</lpage>, <pub-id pub-id-type="doi">10.1016/S2468-2667(18)30200-7</pub-id>.<pub-id pub-id-type="pmid">30467019</pub-id></mixed-citation></ref><ref id="coa14257-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="coa14257-cit-0020"><string-name name-style="western"><given-names>D. C.</given-names><surname>Butler</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Petterson</surname></string-name>, <string-name name-style="western"><given-names>R. L.</given-names><surname>Phillips</surname></string-name>, and <string-name name-style="western"><given-names>A. W.</given-names><surname>Bazemore</surname></string-name>, &#8220;<article-title>Measures of Social Deprivation That Predict Health Care Access and Need Within a Rational Area of Primary Care Service Delivery</article-title>,&#8221; <source>Health Services Research</source><volume>48</volume>, no. <issue>2pt1</issue> (<year>2013</year>): <fpage>539</fpage>&#8211;<lpage>559</lpage>, <pub-id pub-id-type="doi">10.1111/j.1475-6773.2012.01449.x</pub-id>.<pub-id pub-id-type="pmid">22816561</pub-id><pub-id pub-id-type="pmcid">PMC3626349</pub-id></mixed-citation></ref><ref id="coa14257-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="coa14257-cit-0021"><string-name name-style="western"><given-names>J. T.</given-names><surname>Castle</surname></string-name>, &#8220;<article-title>Cholesteatoma Pearls: Practical Points and Update</article-title>,&#8221; <source>Head and Neck Pathology</source><volume>12</volume>, no. <issue>3</issue> (<year>2018</year>): <fpage>419</fpage>&#8211;<lpage>429</lpage>, <pub-id pub-id-type="doi">10.1007/s12105-018-0915-5</pub-id>.<pub-id pub-id-type="pmid">30069838</pub-id><pub-id pub-id-type="pmcid">PMC6081285</pub-id></mixed-citation></ref><ref id="coa14257-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="coa14257-cit-0022"><string-name name-style="western"><given-names>B. D.</given-names><surname>Djurhuus</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Christensen</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Skytthe</surname></string-name>, and <string-name name-style="western"><given-names>C. E.</given-names><surname>Faber</surname></string-name>, &#8220;<article-title>The Impact of Ventilation Tubes in Otitis Media on the Risk of Cholesteatoma on a National Level</article-title>,&#8221; <source>International Journal of Pediatric Otorhinolaryngology</source><volume>79</volume>, no. <issue>4</issue> (<year>2015</year>): <fpage>605</fpage>&#8211;<lpage>609</lpage>, <pub-id pub-id-type="doi">10.1016/j.ijporl.2015.02.005</pub-id>.<pub-id pub-id-type="pmid">25724629</pub-id></mixed-citation></ref><ref id="coa14257-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="coa14257-cit-0023"><string-name name-style="western"><given-names>J.</given-names><surname>Cutajar</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Nowghani</surname></string-name>, <string-name name-style="western"><given-names>B.</given-names><surname>Tulsidas&#8208;Mahtani</surname></string-name>, and <string-name name-style="western"><given-names>J.</given-names><surname>Hamilton</surname></string-name>, &#8220;<article-title>The Natural History of Asymptomatic Deep Pars Tensa Retraction</article-title>,&#8221; <source>Journal of International Advanced Otology</source><volume>14</volume> (<year>2018</year>): <fpage>10</fpage>&#8211;<lpage>14</lpage>, <pub-id pub-id-type="doi">10.5152/iao.2018.5234</pub-id>.<pub-id pub-id-type="pmid">29764774</pub-id><pub-id pub-id-type="pmcid">PMC6354506</pub-id></mixed-citation></ref><ref id="coa14257-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="coa14257-cit-0024"><string-name name-style="western"><given-names>M.</given-names><surname>Lyoubi</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Douimi</surname></string-name>, <string-name name-style="western"><given-names>Z.</given-names><surname>El Krimi</surname></string-name>, et&#160;al., &#8220;<article-title>Management of the Association of Otosclerosis and Cholesteatoma: Which Pathology to Treat First?</article-title>,&#8221; <source>International Journal of Surgery Case Reports</source><volume>96</volume> (<year>2022</year>): <elocation-id>107281</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.ijscr.2022.107281</pub-id>.<pub-id pub-id-type="pmid">35724500</pub-id><pub-id pub-id-type="pmcid">PMC9218369</pub-id></mixed-citation></ref><ref id="coa14257-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="coa14257-cit-0025"><string-name name-style="western"><given-names>M.</given-names><surname>Ealy</surname></string-name> and <string-name name-style="western"><given-names>R. J. H.</given-names><surname>Smith</surname></string-name>, &#8220;<article-title>The Genetics of Otosclerosis</article-title>,&#8221; <source>Hearing Research</source><volume>266</volume>, no. <issue>1&#8211;2</issue> (<year>2010</year>): <fpage>70</fpage>&#8211;<lpage>74</lpage>, <pub-id pub-id-type="doi">10.1016/j.heares.2009.07.002</pub-id>.<pub-id pub-id-type="pmid">19607896</pub-id></mixed-citation></ref><ref id="coa14257-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="coa14257-cit-0026"><string-name name-style="western"><given-names>M. F.</given-names><surname>Bhutta</surname></string-name>, <string-name name-style="western"><given-names>I. G.</given-names><surname>Williamson</surname></string-name>, and <string-name name-style="western"><given-names>H. H.</given-names><surname>Sudhoff</surname></string-name>, &#8220;<article-title>Cholesteatoma</article-title>,&#8221; <source>British Medical Journal (BMJ)</source><volume>342</volume>, no. <issue>1</issue> (<year>March 2011</year>): <elocation-id>d1088</elocation-id>, <pub-id pub-id-type="doi">10.1136/bmj.d1088</pub-id>.<pub-id pub-id-type="pmid">21372073</pub-id></mixed-citation></ref><ref id="coa14257-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="coa14257-cit-0027"><string-name name-style="western"><given-names>L.</given-names><surname>Migirov</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Duvdevani</surname></string-name>, and <string-name name-style="western"><given-names>J.</given-names><surname>Kronenberg</surname></string-name>, &#8220;<article-title>Otogenic Intracranial Complications: A Review of 28 Cases</article-title>,&#8221; <source>Acta Oto&#8208;Laryngologica</source><volume>125</volume>, no. <issue>8</issue> (<year>2005</year>): <fpage>819</fpage>&#8211;<lpage>822</lpage>, <pub-id pub-id-type="doi">10.1080/00016480510038590</pub-id>.<pub-id pub-id-type="pmid">16158527</pub-id></mixed-citation></ref><ref id="coa14257-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="coa14257-cit-0028"><string-name name-style="western"><given-names>Y.</given-names><surname>Deng</surname></string-name>, <string-name name-style="western"><given-names>Y.</given-names><surname>Ren</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Wang</surname></string-name>, and <string-name name-style="western"><given-names>Y.</given-names><surname>Zhang</surname></string-name>, &#8220;<article-title>Clinical Features and Prognosis of Cerebellopontine Angle Cholesteatoma in 54 Patients</article-title>,&#8221; <source>International Journal of Clinical and Experimental Medicine</source><volume>13</volume>, no. <issue>6</issue> (<year>2020</year>): <fpage>4426</fpage>&#8211;<lpage>4433</lpage>.</mixed-citation></ref><ref id="coa14257-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="coa14257-cit-0029"><string-name name-style="western"><given-names>M. R.</given-names><surname>Keezer</surname></string-name>, <string-name name-style="western"><given-names>S. M.</given-names><surname>Sisodiya</surname></string-name>, and <string-name name-style="western"><given-names>J. W.</given-names><surname>Sander</surname></string-name>, &#8220;<article-title>Comorbidities of Epilepsy: Current Concepts and Future Perspectives</article-title>,&#8221; <source>Lancet Neurology</source><volume>15</volume>, no. <issue>1</issue> (<year>2016</year>): <fpage>106</fpage>&#8211;<lpage>115</lpage>, <pub-id pub-id-type="doi">10.1016/S1474-4422(15)00225-2</pub-id>.<pub-id pub-id-type="pmid">26549780</pub-id></mixed-citation></ref><ref id="coa14257-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="coa14257-cit-0030"><string-name name-style="western"><given-names>P.</given-names><surname>Pelc</surname></string-name>, <string-name name-style="western"><given-names>N.</given-names><surname>Vanmuylder</surname></string-name>, <string-name name-style="western"><given-names>F.</given-names><surname>Lefranc</surname></string-name>, et&#160;al., &#8220;<article-title>Differential Expression of S100 Calcium&#8208;Binding Proteins in Epidermoid Cysts, Branchial Cysts, Craniopharyngiomas and Cholesteatomas</article-title>,&#8221; <source>Histopathology</source><volume>42</volume>, no. <issue>4</issue> (<year>2003</year>): <fpage>387</fpage>&#8211;<lpage>394</lpage>, <pub-id pub-id-type="doi">10.1046/j.1365-2559.2003.01588.x</pub-id>.<pub-id pub-id-type="pmid">12653951</pub-id></mixed-citation></ref><ref id="coa14257-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="coa14257-cit-0031"><string-name name-style="western"><given-names>A.</given-names><surname>Fry</surname></string-name>, <string-name name-style="western"><given-names>T. J.</given-names><surname>Littlejohns</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Sudlow</surname></string-name>, et&#160;al., &#8220;<article-title>Comparison of Sociodemographic and Health&#8208;Related Characteristics of UK Biobank Participants With Those of the General Population</article-title>,&#8221; <source>American Journal of Epidemiology</source><volume>186</volume>, no. <issue>9</issue> (<year>2017</year>): <fpage>1026</fpage>&#8211;<lpage>1034</lpage>, <pub-id pub-id-type="doi">10.1093/aje/kwx246</pub-id>.<pub-id pub-id-type="pmid">28641372</pub-id><pub-id pub-id-type="pmcid">PMC5860371</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>